Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Bats are nature's longevity champions — and their DNA might tell us why. A new study in Nature found that long-lived bat species combine supercharged immune defenses with a ruthless strategy of destroying damaged cells before they turn cancerous. Researchers believe these genetic tricks could eventually point to new ways to fight aging and disease in humans.
Bats are nature's longevity champions — and their DNA might tell us why. A new Nature study from UC Berkeley analyzed eight genomes from the Myotis bat genus, which includes species with dramatically different lifespans — some living just 7 years, others surviving 50+. The longer-lived species showed higher activity of cancer-fighting genes and a supercharged immune system that stays on high alert throughout their lives, even while hosting a wide variety of viruses without getting sick.
One of the most striking findings: when researchers exposed cells from the longest-lived North American bat to toxic chemicals, the cells didn't try to repair the damage — they self-destructed. This "kill the cell" strategy, also seen in cancer-resistant elephants, may be a key evolutionary mechanism to prevent damaged cells from becoming tumors.
Researchers also found significant overlap between genes linked to bat longevity and genes involved in virus defense — far more than chance would predict — suggesting aging resistance and infection resistance may be two sides of the same coin.
Key Takeaways:
Why it matters: Understanding how bats evolved to resist cancer and infectious disease could open entirely new avenues for human medicine — from anti-aging therapies to novel immune-based cancer treatments.
